Cancer Research Funding

Share

Cancer research saves lives.   

Every new breakthrough in freeing the world from the pain and suffering of cancer - from new cures to innovative ways to prevent and treat the disease - have one thing in common; the research was in some way funded by the federal government's National Institutes of Health and the National Cancer Institute.   

Yet, when adjusting for inflation, federal funding for cancer research has seen huge cuts over the last decade. Increasing funding for cancer research must be a top budget priority for Congress.  

Take Action

Test tubes

Congress: Increase funding for cancer research

As Congress negotiates a final budget for the coming year, it's critical that they make fighting cancer a top priority.

Latest Updates

May 5, 2021
National

A new report from the American Cancer Society Cancer Action Network (ACS CAN) takes an in-depth look at disparities across all areas of cancer research and suggests immediate policy solutions that could help address such gaps in the years to come.

May 3, 2021
National

A group of more than fifty cancer research-focused organizations are urging Congress to include $10 billion in emergency funding to restart cancer research and clinical trials at the National Institutes of Health (NIH) stalled by the coronavirus pandemic.

April 28, 2021
National

ACS CAN President Lisa Lacasse reacts to President Biden's declaration we will, "End cancer as we know it." The statement was part of the president's address to a joint session of Congress.

April 12, 2021
Louisiana

BATON ROUGE, LA – As lawmakers dive into the new legislative session, the American Cancer Society Cancer Action Network (ACS CAN) looks ahead to what public health initiatives our lawmakers can accomplish during the 2021 legislative session. Long after this pandemic passes, people deserve to live full, healthy lives.

Cancer Research Funding Resources

The National Program of Cancer Registries (NPCR) at the Centers for Disease Control and Prevention (CDC) provides technical, operational, and financial support to almost all state cancer registries to help ensure data collected are representative of the U.S. population.